The global Novel Drug Delivery Systems market is valued at 26500 million US$ in 2017 and will reach 31100 million US$ by the end of 2025, growing at a CAGR of 2.0% during 2018-2025.

City of Industry, CA -- (SBWire) -- 07/14/2018 --This report studies the global Novel Drug Delivery Systems market status and forecast, categorizes the global Novel Drug Delivery Systems market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.

Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.

The classification of Novel Drug Delivery Systems includes Liposomes, PEGylated Proteins & Polypeptides, Polymer Nanoparticle, Protein–drug Conjugates, and the proportion of PEGylated Proteins & Polypeptides in 2017 is about 39.60%, and the proportion is in decreasing trend from 2013 to 2017.

North America is the largest consumption place, with a consumption market share nearly 49.69% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 26.15%.

The global Novel Drug Delivery Systems market is valued at 26500 million US$ in 2017 and will reach 31100 million US$ by the end of 2025, growing at a CAGR of 2.0% during 2018-2025.

Request Sample Copy of the Report @ https://www.qyresearch.com/sample-form/form/581532/global-novel-drug-delivery-systems-sales-market

The major players covered in this report

Amgen

Teva

UCB (Union Chimique Belge)

Roche

Celgene

Sanofi

Merck

Johnson & Johnson

Takeda

Gilead Sciences

Pfizer

Dr Reddy

Samyang Biopharmaceuticals

TOLMAR

Astellas

AMAG Pharmaceuticals

AstraZeneca

AbbVie

Bausch?Lomb

TWi Pharmaceuticals

Novartis

Aspen

Shire

Breckenridge Pharmaceuticals

Galen

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

United States

Europe

China

Japan

Southeast Asia

India

Click to view the full report TOC, figure and tables: https://www.qyresearch.com/index/detail/581532/global-novel-drug-delivery-systems-sales-market

About QY Research
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.